ATX-101 in Advanced Dedifferentiated Liposarcoma and Leiomyosarcoma
NCT05116683
·
clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
4
Enrollment
OTHER
Sponsor class
Stopped
Study terminated by PI
Conditions
Leiomyosarcoma
Liposarcoma
Interventions
DRUG:
ATX-101
Sponsor
Benjamin Izar